Excessive apoptosis accelerates the decline in ovarian reserve, a phenomenon particularly evident in conditions such as DOR, premature ovarian insufficiency (POI), and premature ovarian failure (POF)
Note the volume (light spotting, moderate flow, heavy bleeding), colour, and any associated symptoms such as cramping, bloating, or mood changes
And North Carolina Medicaid announced it would no longer cover Wegovy or Zepbound except for diabetes or heart uses
Really, what has happened over the last year we have talked about in previous episodes is that the three insulin manufacturers in the United States, Sanofi, Novo Nordisk, and Lilly have decided that theyre going to have a cap of $35 for all patients, not just Medicare patients, which Inflation Reduction Act does